House Memorial 58 requests the New Mexico Department of Health to conduct a comprehensive study on psilocybin-based medication treatment, recognizing the growing interest in its therapeutic potential for mental health conditions such as depression, anxiety, and PTSD. The memorial outlines several key areas for investigation, including the standardization of training requirements for medical professionals, the establishment of testing protocols for psilocybin products, and the review of existing legal and regulatory barriers. It emphasizes the need for guidelines that ensure safety, efficacy, and accessibility of psilocybin treatments, as well as considerations for public health and economic equity.

Additionally, the memorial calls for the engagement of medical and scientific experts, input from various stakeholders, and the identification of funding sources to support future research and implementation efforts. The Department of Health is also tasked with submitting a comprehensive report detailing findings, recommended policy changes, and a proposed framework for psilocybin-based medication treatment, which may include pilot programs and licensing structures. This initiative aims to inform future policymaking efforts and enhance the understanding and regulation of psilocybin treatments in New Mexico.